Cromwell Holdings LLC Purchases New Holdings in Humana Inc. (NYSE:HUM)

Cromwell Holdings LLC bought a new position in Humana Inc. (NYSE:HUM) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 285 shares of the insurance provider’s stock, valued at approximately $73,000.

A number of other institutional investors have also bought and sold shares of HUM. Creative Financial Designs Inc. ADV lifted its stake in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares in the last quarter. Ashton Thomas Securities LLC purchased a new position in Humana in the 3rd quarter worth approximately $31,000. Your Advocates Ltd. LLP lifted its stake in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares in the last quarter. Atwood & Palmer Inc. lifted its stake in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new position in Humana in the 4th quarter worth approximately $49,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Up 2.4 %

Humana stock opened at $271.87 on Friday. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a 50 day moving average price of $269.78 and a 200 day moving average price of $291.15. The company has a market capitalization of $32.74 billion, a PE ratio of 27.32, a price-to-earnings-growth ratio of 1.94 and a beta of 0.56.

Humana (NYSE:HUM) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts expect that Humana Inc. will post 16.49 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.30%. Humana’s dividend payout ratio (DPR) is 35.58%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Morgan Stanley decreased their target price on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Piper Sandler lifted their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $290.00 price target on shares of Humana in a research report on Wednesday, February 12th. Finally, TD Cowen lifted their price target on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Humana currently has an average rating of “Hold” and an average target price of $285.68.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.32% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.